IV crotoxin for advanced solid tumors that progressed
Part of Cancer clinical trials.
This early-phase study tests an IV drug called crotoxin in adults with advanced solid tumors that have worsened or for which no standard treatment exists. It aims to see whether the drug can be given safely and whether it can shrink or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older, with an advanced solid tumor confirmed by biopsy
- Your cancer is not basal cell skin cancer, colon cancer, pancreatic cancer, or stomach cancer
- You can do usual daily activities (you’re not bedbound) and your doctor expects you may live more than 3 months
- You finished prior cancer treatment (chemo/radiation/other) more than 4 weeks ago and you recovered from side effects
- Your blood counts, kidneys, liver, and breathing/heart function are in safe ranges for treatment
- You can meet study rules like not being pregnant, no severe allergy to venoms, and having a safe place and phone access for follow-up
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called CR-001 in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if CR-001 can slow or stop tumor growth.
This trial tests a new drug (an ATR inhibitor) for people with advanced solid tumors that have not responded to or are not suitable for standard treatments. It aims to see if the drug is safe and effective, and it may be an option if you have good heart function and are feeling well enough to participate.
This trial tests an experimental drug called rilvegostomig, given as a shot under the skin, for people with advanced solid tumors that have spread or can't be removed and have already had standard treatments. The study checks how the body processes the drug and its safety.
This trial tests an experimental drug (TGRX-1942) for people with advanced solid tumors or blood cancers that have stopped responding to standard treatments. The main goal is to find a safe dose and see how well the drug works.
This study is testing a new drug called CX-2051 for people with advanced solid tumors that have not responded to standard treatments. The drug is a type of targeted therapy that delivers chemotherapy directly to cancer cells, and the goal is to see if it is safe and effective.
This trial tests a new drug called STX-001, which is injected directly into a tumor to help the immune system fight cancer. It is being studied alone or with another immunotherapy (pembrolizumab) for people with advanced solid tumors, including melanoma or triple-negative breast cancer.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.